Which institution holds the most shares in SELLAS Life Sciences Group Inc (SLS)

SELLAS Life Sciences Group Inc (NASDAQ: SLS) is -26.78% lower on its value in year-to-date trading and has touched a low of $0.50 and a high of $3.98 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SLS stock was last observed hovering at around $0.73 in the last trading session, with the day’s gains setting it 0.05%.

Currently trading at $0.78, the stock is 37.68% and -6.04% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.41 million and changing 6.32% at the moment leaves the stock -40.49% off its SMA200. SLS registered -78.50% loss for a year compared to 6-month loss of -50.57%. The firm has a 50-day simple moving average (SMA 50) of $20.84 and a 200-day simple moving average (SMA200) of -$0.78.

Invest Like Buffett: Travel Back in Time & Grab This High-Potential Stock Before It Explodes

Imagine buying Apple for $1, Amazon for $2, or Tesla for $3. Now, imagine the same opportunity with a hidden gem trading under $3 right now.

Our premium newsletter, powered by AI and expert analysis, uncovers these time-travel investment opportunities.

Invest like Buffett and profit from undervalued gems before the market catches on.

Limited-time offer: Get your first month for just $2.90 and start your journey to wealth creation.


The stock witnessed a 35.54% gain in the last 1 month and extending the period to 3 months gives it a -19.99%, and is 29.89% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.28% over the week and 8.76% over the month.

SELLAS Life Sciences Group Inc (SLS) has around 17 employees, a market worth around $32.80M and $0.00M in sales. Distance from 52-week low is 55.66% and -80.50% from its 52-week high.

SELLAS Life Sciences Group Inc quarterly earnings per share for the current quarter are estimated at $0.09 with sales reaching $13M over the same period.The EPS is expected to grow by 48.71% this year, but quarterly earnings will post 1,200.00% year-over-year.

34 institutions hold shares in SELLAS Life Sciences Group Inc (SLS), with institutional investors hold 8.45% of the company’s shares. The shares outstanding are 42.26M, and float is at 41.75M with Short Float at 9.30%. Institutions hold 8.39% of the Float.

The top institutional shareholder in the company is Alyeska Investment Group, L.p. with over 1.25 million shares valued at $1.96 million. The investor’s holdings represent 4.41% of the SLS Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 0.95 million shares valued at $1.49 million to account for 3.34% of the shares outstanding. The other top investors are Blackrock Inc. which holds 0.28 million shares representing 1.00% and valued at over $0.44 million, while Geode Capital Management, LLC holds 0.66% of the shares totaling 0.19 million with a market value of $0.3 million.

SELLAS Life Sciences Group Inc (SLS) Insider Activity

A total of 0 insider transactions have happened at SELLAS Life Sciences Group Inc (SLS) in the last six months, with sales accounting for 0 and purchases happening 0 times.